Neuronal Reprogramming Drives Bevacizumab Resistance in Glioblastoma via the NRG3–ERBB4–CTNNB1 Axis
Year: 2025
Type: preprint
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.5532274
Authors: Sung Soo Kim, Ji Yoon Lee, Harim Koo, Kyung-Hee Kim, Zheng Yuan, Hyung Joon Kwon, Sewhan Park, Sunil Choi, Yong-Seok Oh, Bingyang Shi, xuechen Tian, Yixin Yang, Antonio Iavarone, Ho-Shin Gwak, Heon Yoo, Seong-Min Park, Jason K. Sa, Jinlong Yin, Jong Bae Park
Institutions: Government of the United States of America, National Cancer Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Henan University, Daegu Gyeongbuk Institute of Science and Technology, Macquarie University, Kean University, National Cancer Center, National Cancer Center Hospital
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4414643258